Who are traditional IVM system's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Oral ivermectin, Ivermectin + colchicine, ''albendazole'' and ''ivermectin'', Ivermectin 1% cream (IVM), Ivermectin 1% cream, IVM plus ALB.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/traditional-ivm-system.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

traditional IVM system — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

traditional IVM system (traditional IVM system) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glutamate-gated chloride channel agonist. Area: Parasitology.

phase 3 Glutamate-gated chloride channel agonist Glutamate-gated chloride channel Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

traditional IVM system (traditional IVM system) — Sun Yat-sen University. Ivermectin acts as a glutamate-gated chloride channel agonist.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
traditional IVM system TARGET	traditional IVM system	Sun Yat-sen University	phase 3	Glutamate-gated chloride channel agonist	Glutamate-gated chloride channel
Oral ivermectin	Oral ivermectin	University of Oxford	marketed	Macrocyclic lactone antiparasitic	Glutamate-gated chloride channels (GluCl)
Ivermectin + colchicine	Ivermectin + colchicine	Ain Shams University	marketed	Antiparasitic + anti-inflammatory combination	Glutamate-gated chloride channels (ivermectin); tubulin/microtubules (colchicine)
''albendazole'' and ''ivermectin''	''albendazole'' and ''ivermectin''	Centre d'Appui à la lutte contre la Maladie	marketed	Antihelmintic/Antiparasitic agents	β-tubulin (albendazole); glutamate-gated chloride channels (ivermectin)
Ivermectin 1% cream (IVM)	Ivermectin 1% cream (IVM)	Galderma R&D	marketed	Antiparasitic agent	Glutamate-gated chloride channels (invertebrate-specific)
Ivermectin 1% cream	Ivermectin 1% cream	Insel Gruppe AG, University Hospital Bern	marketed	Antiparasitic agent	Glutamate-gated chloride channels
IVM plus ALB	IVM plus ALB	University Hospitals Cleveland Medical Center	phase 3	Antiparasitic combination	Glutamate-gated chloride channels (ivermectin); beta-tubulin (albendazole)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glutamate-gated chloride channel agonist class)

Sun Yat-sen University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). traditional IVM system — Competitive Intelligence Brief. https://druglandscape.com/ci/traditional-ivm-system. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing